Anestesia para cirurgia ortopédica em criança com susceptibilidade à hipertermia maligna: relato de caso
Anesthesia for orthopedic surgery in a child susceptible to malignant hyperthermia: case report
Renato Santiago Gomez; Yerkes Pereira Silva; Cristiano Pereira Peluso
Resumo
Palavras-chave
Abstract
Keywords
Referências
Jurkat-Rott K, McCarthy T, Lehmann-Horn F. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve. 2000;23:4-17.
Levitt RC. Prospects for the diagnosis of malignant hyperthermia susceptibility using molecular genetic approaches. Anesthesiology. 1992;76:1039-1048.
Wappler F. Malignant hyperthermia. Eur J Anaesthesiol. 2001;18:632-652.
Denborough M. Malignant hyperthermia. Lancet. 1998;352:1131-1136.
Nelson TE, Flewellen EH. The malignant hyperthermia syndrome. N Engl J Med. 1983;309:416-418.
Ball SP, Johnson KJ. The genetics of malignant hyperthermia. J Med Genet. 1993;30:89-93.
Larach MG. Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility. Anesthesiology. 1993;79:1-4.
A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth. 1985;56:1267-1269.
Standardization of the caffeine halothane muscle contracture test. Anesth Analg. 1989;69:511-515.
Fletcher JE, Rosenberg H, Aggarwal M. Comparison of European and North American malignant hyperthermia diagnostic protocol outcomes for use in genetic studies. Anesthesiology. 1999;90:654-661.
Rosenberg H, Fletcher JE, Seitman D. Pharmacogenetics. Clinical Anesthesia. 1997:489-517.
Allen GC, Brubaker CL. Human malignant hyperthermia associated with desflurane anesthesia. Anesth Analg. 1998;86:1328-1331.
Larach MG, Localio AR, Allen GC. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994;80:771-779.
Rosenberg H, Reeds S. In vitro contracture tests for susceptibility to malignant hyperthermia: diagnostic dilemma. Anesth Analg. 1983;62:415-420.